Pubblicazioni

Screening program in ovarian cancer: a logical step in clinical management? A meta-analysis

2018 - CURRENT PROBLEMS IN CANCER
Marchetti, Claudia; De Felice, Francesca; Perniola, Giorgia; Lecce, Francesca; Vertechy, Laura; Monti, Marco; Musio, Daniela; Muzii, Ludovico; Tombolini, Vincenzo; Benedetti Panici, Pierluigi

Genetic versus epigenetic BRCA1 silencing pathways: clinical effects in primary ovarian cancer patients. A study of the tumor bank ovarian cancer consortium

2017 - INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Sun, T; Ruscito, I; Dimitrova, D; Chekerov, R; Kulbe, H; Baron, U; Blanchard, V; Panici, Pb; Darb-Esfahani, S; Sehouli, J; Olek, S; Braicu, E. I.

Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium

2016 - TUMOR BIOLOGY
Dimitrova, D; Ruscito, I; Olek, S; Richter, R; Hellwag, A; Türbachova, I; Woopen, H; Baron, U; Braicu, Ei; Sehouli, J.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma